Skip to main content

Displaying 2149 - 2160 of 12380

All Star Charts Premium

‘Tis the Season For Dollar Weakness

December 14, 2023

From the Desk of Ian Culley @IanCulley

Bing Crosby dreamed of a White Christmas.

Who hasn’t?

Growing up, I wished for a white Christmas every year. I knew snow was a stretch living in Florida. But a kid can dream… 

This season, stock market bulls hope for quite a different, serene vision: a weaker dollar.

Based on the charts, they might just get their wish.

Check out the updated US Dollar Index $DXY chart:

DXY has respected key retracement levels on the way up and down over the past six months. The repeated touches add to my conviction in these levels.

Today’s breakdown below 102.54 suggests further weakness toward the year-to-date lows. A fall to those former lows would undoubtedly stir tailwinds for global equities, producing joy and cheer among investors worldwide.

The 102 area also carries...

All Star Charts Premium

Young Aristocrats (December 2023)

December 14, 2023

From the Desk of Steve Strazza @Sstrazza

Dividend Aristocrats are easily some of the most desirable investments on Wall Street. These are the names that have increased dividends for at least 25 years, providing steadily increasing income to long-term-minded shareholders.

As you can imagine, the companies making up this prestigious list are some of the most recognizable brands in the world. Coca-Cola, Walmart, and Johnson & Johnson are just a few of the household names making the cut.

Here at All Star Charts, we like to stay ahead of the curve. That's why we're turning our attention to the future aristocrats. In an effort to seek out the next generation of the cream-of-the-crop dividend plays, we're curating a list of stocks that have raised their payouts every year for five to nine years.

We call them the Young Aristocrats, and the idea is that these are "stocks that pay you to make money." Imagine if years of consistent dividend growth and high momentum and relative strength had a baby, leaving you with the best of the emerging dividend giants that are outperforming the averages.

By adding our technical analysis to the mix,...

Buffett's Into OXY for Another $588 Million

December 14, 2023

From the Desk of Steve Strazza and Alfonso Depablos

The most significant transaction on today’s list comes in a Form 4 filing by Warren Buffett and Berkshire Hathaway.

Buffett reported another substantial purchase in Occidental Petroleum Corp $OXY, this time with a total value of $588 million.

You See? Stock Prices Trend

December 14, 2023

As you may have expected, the Dow Jones Industrial Average is making new all-time highs.

This week we saw the most amount of stocks hitting new 52-week highs in over 2 years.

That's what happens in bull markets:

All Star Charts Premium

The Short Report (12-13-2023)

December 14, 2023

From the Desk of Steve Strazza @Sstrazza

When investing in the stock market, we always want to approach it as "a market of stocks."

Regardless of the environment, there are always stocks showing leadership and trending higher.

We may have to look harder to identify them depending on current market conditions. But there are always stocks that are going up.

The same can be said for weak stocks. Regardless of the environment, there are always stocks that are going down, too. 

We already have multiple scans focusing on stocks making all-time highs, such as Hall of Famers, Minor Leaguers, and the 2 to 100 Club.

We filter these universes for stocks that are exhibiting the best momentum and relative strength characteristics. 

Clearly, we spend a lot of time identifying and writing about leading stocks every week, via multiple reports.

Now, we're also highlighting lagging stocks on a recurring basis.

Welcome to the Short Report.

We...

All Star Charts Premium,
All Star Charts Gold Rush

How To Play Gold’s False Start

December 13, 2023

From the Desk of Ian Culley @IanCulley

Last week’s fresh all-time highs left many gold bugs empty-hearted. 

The market continues to torment precious metal bulls as they wonder what could have been.

But hopes and dreams aren’t a viable strategy.

The only “what if” that concerns me is whether the yellow metal flashed a failed breakout.

Or are we simply dealing with a a premature move?

Let’s dig in…

All Star Charts Gold Rush

How To Play Gold’s False Start

December 13, 2023

From the Desk of Ian Culley @IanCulley

Last week’s fresh all-time highs left many gold bugs empty-hearted. 

The market continues to torment precious metal bulls as they wonder what could have been.

But hopes and dreams aren’t a viable strategy.

The only “what if” that concerns me is whether the yellow metal flashed a failed breakout.

Or are we simply dealing with a a premature move?

Let’s dig in…

Check out the weekly chart of gold futures, highlighting the breakout in question:

 

Bulls sliced through overhead supply, vaulting gold to new heights. But the bearish momentum divergence in the lower pane reveals a lack of fervor for the shiny yellow rock.

Divergences between momentum and price don’t guarantee a major reversal.

Gold can still break out as momentum divergences have a way of righting themselves. That’s why I prefer to focus on momentum regimes. They’re just more reliable.

From a structural perspective, the real nail in the coffin for gold lies just below the right shoulder trough at approximately 1,820. A decisive close below that level completes a failed inverted head-and-...

Cormorant Reports a $10 Million EYPT Buy

December 13, 2023

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a Form 4 filing by Cormorant Asset Management LP.

The investment firm reported the acquisition of 588,235 shares of EyePoint Pharmaceuticals Inc $EYPT, equivalent to roughly $10 million.